We are often asked about placement agents – by managers wondering whether to hire one, by managers halfway through negotiating an engagement letter who sense the form was not written with them in mind, and, more often than anyone admits, by managers a year into a mandate trying to understand what exactly they bought. The questions have a particular intensity because of a fact worth stating in the first paragraph: the placement agent is the most expensive outside hire a fund manager ever makes, and the manager pays for it personally. Unlike fund counsel, the auditor or the administrator, the agent’s fee is not a fund expense. It comes out of the management company’s pocket – and even in the structures where the fund technically writes the check, the documents route the cost straight back to the manager through a dollar-for-dollar reduction in the management fee. The market has exactly one nonnegotiable term, and that is it: investors will not pay your cost of selling to them.
First, a scope note. Our subject is the third-party placement agent engaged to raise primary capital for a private equity or venture capital fund – the registered broker-dealer retained under an engagement letter or mandate agreement to find, cultivate and close limited partners. We are not writing about the in-house investor relations team (a build-versus-buy question we touch only in passing), about finders and unregistered intermediaries (a regulatory third rail we touch below exactly once, to mark it), or about the secondary and GP-led advisory businesses that increasingly live inside the same firms – though one of this primer’s findings is that the primary engagement letter has begun reaching toward those adjacent businesses, and any manager signing one should understand the reach. A second scope note, and it doubles as this primer’s first finding: usage splits sharply by industry, and any single number hides the fork. In venture capital, placement agents are the exception – blended market studies put agent usage across all closed private funds at roughly an eighth, venture running below even that, and in our venture practice the figure is more like one manager in ten – and the decision to hire one is a genuine decision, freighted with signaling, taken in a market where the strongest franchises are oversubscribed by construction and fund sizes are too small to feed much of an agent ecosystem.
In institutional private equity, agents are closer to standard infrastructure: in the years before the largest firms internalized distribution into in-house investor relations teams, roughly half the funds in market globally were using one, and on today’s institutional raises professional distribution – external or internal – is simply assumed. Ask a venture lawyer how common placement agents are and you will hear “rare”; ask a buyout lawyer and you will hear “everyone serious”; both are describing their own desks accurately. This primer serves both markets, and the fork runs through everything that follows: the venture reader’s threshold question is usually whether; the private equity reader’s is usually which firm, what scope, and on what terms. Both readers sign the same letters, which is why the second half of this primer belongs to everyone – including everyone who will someday be handed the agent’s form and asked to sign it by Friday.
This primer also rests, in part, on an unusual source: we recently reviewed a large number of placement agent engagement letters and mandate agreements – executed documents spanning the last half-dozen years, across agents large and small, US and non-US, and funds from the low hundreds of millions to the billions – and mapped their terms against each other and against time. We will draw on that review throughout, not as statistics for their own sake but for what the drafting reveals about the commercial bargain: what agents ask for, what managers concede, what has quietly changed. The single largest change is worth previewing because it organizes much of what follows: the modern engagement letter has evolved from selling a fundraise into optioning a franchise. The fee for this fund is now, in the most recent documents, accompanied by machinery reaching for the next fund, the fund after that, and the transactions in between. Managers price the first thing carefully and the second thing hardly at all.
At a high level, three questions determine almost everything about a placement agent engagement:
- Do you actually need one – and which market’s version of that question are you asking? In venture, the question is live and the default answer is no: there are a small number of legitimate reasons to pay this much for help, each a specific, nameable gap between the LP roster you have and the LP roster you need – and one pervasive illegitimate reason, which is wanting to be bigger. In institutional private equity, professional distribution is the baseline and the question migrates: not whether, but which firm, at what scope, on what terms – with the same illegitimate reason lurking unchanged.
- Whose relationships are you actually buying? Not the firm’s brand – the actual Rolodex of the actual two or three people who will work your mandate. This is the question managers skip most often and regret most expensively, because an agent’s relationships are not generic: they are particular institutions of particular types, and if they are the wrong types for your fund, the agent will still produce checks – the wrong checks.
- What does the engagement reach beyond this fund? Tails, successor-fund rights, trailer fees, secondary and continuation-vehicle mandates – the parts of the letter priced at zero on signing day and discovered at full price years later. The reach has been growing, and it is the part of the negotiation where the manager is pledging the franchise, not the fundraise.
These questions are related, but they are not the same. A manager can need an agent for exactly the right reason and still buy the wrong Rolodex; a manager can buy the right Rolodex and still pledge the next decade in the boilerplate. We will take all three in turn, but first, some terminology.
A note on terminology
A few terms recur throughout this post and repay precision.
A placement agent is a registered broker-dealer engaged by a fund sponsor to place limited partnership interests with investors – the registration is not a formality but the entry ticket, for reasons the regulatory map explains. The contract is an engagement letter (US-style) or mandate agreement (the UK and European houses’ longer form); both do the same work. The agent’s compensation has two standard components: a retainer (a monthly or upfront fee, usually creditable against success fees, that pays for the agent’s attention regardless of outcome) and the success fee or placement fee – a percentage of capital commitments, but which commitments is the entire game. Included investors, excluded investors and their many cousins (specified investors, no-fee investors, schedule B investors) are the defined terms that sort the register into fee classes: full-fee names, reduced-fee names, and the carve-out of relationships the manager already owned. The “introduced” definition – what an agent must actually have done to earn credit for an investor – is where these classifications get their teeth, or fail to.
The tail is the period after termination during which commitments from covered investors still generate fees; a trailer fee or successor fund fee extends the agent’s economics into the next fund; a right of first offer on the successor mandate converts the agent from vendor to incumbent. A sub-agent is the local affiliate or third-party firm through which global mandates reach specific geographies, with the primary agent typically remaining liable for its conduct and sharing its fee. A completion or top-up mandate is the mid-raise engagement – an agent hired after the fundraise has stalled. In-house investor relations is the internalized alternative – the permanent distribution teams at the largest sponsors that do the agent’s job from inside the management company – and is the reason the biggest firms rarely appear on agents’ client lists: build versus buy, decided at scale. And a regulated person, in the pay-to-play sense, is what an agent must be before it may solicit US government investors at all – the survival adaptation of an industry that nearly did not survive its 2009 scandals, discussed below. (For the management fee that funds all of this, see our primer on management fees; for how individual investors’ side deals interact with everything here, see our primer on side letters.)
The economics, stated plainly
Before the strategy, the price, because the price disciplines everything – though one sentence of fairness belongs ahead of the numbers: the fee is large because the problem is large. Institutional raises now average a year and a half of principal time, distribution has become the binding constraint of the fundraising market, and what the fee buys, done well, is that constraint professionally managed. The institutional market for success fees runs from roughly one to two and a half percent of commitments, with the working center of gravity in the 1.5 to 2 percent range and real dispersion around it: first-time and sub-scale funds pay a premium – two and a half to three percent, occasionally more on genuinely hard raises – because, as one market commentator put it with unusual candor, the smallest mandate is the least attractive one in the agent’s portfolio. Established relationships price near zero: the documents we reviewed repeatedly carve existing investors out entirely or price them at token rates – ten basis points in one recent agreement, against 175 on new money in the same document – and the most sophisticated forms run three separate schedules (no-fee names, reduced-fee names, full-fee names) with the sorting negotiated line by line. Structures vary more than the folklore suggests. We saw flat rates; declining tiers; and – instructively – escalating tiers, 1.75 percent on the first tranche of commitments rising to 2.25 percent above a threshold, which is not a typo but incentive design: on a hard raise, the marginal dollar is the valuable one, and the fee schedule was built to say so. We saw a fee computed as the average management fee rate the investor will actually pay over the fund’s first three years, floored at 125 basis points – the fee literally indexed to what the relationship is worth – and we saw minimum fees (seven figures, conditioned on the fund reaching a stated size), target bonuses for crossing size thresholds, and discretionary bonuses left to the manager’s grace. Retainers run from ten to twenty-five thousand dollars a month or fifty to a hundred thousand upfront, are usually creditable against success fees, and the crediting mechanics themselves get negotiated – one recent letter credits the retainer only against the final installment, and only if the total fee cleared the minimum.
Then the payment plumbing, which matters more than managers expect because of who bears it. Success fees are almost never paid at closing. The documents spread them across installments – four, six, eight, in one form sixteen quarters – frequently timed to the dates the fund’s management fee is actually paid, which is the market quietly acknowledging where the money comes from. The unpaid balance bears interest: we saw fixed rates from 2.5 to 5 percent, SOFR-based formulas, and late-payment provisions escalating to SOFR plus double digits. Good agreements adjust for reality: if an investor defaults on its first capital call, the fee recalculates as if the investor never existed; if a regulator forces an investor out, the fee adjusts pro rata. A manager should insist on those mechanics and read them twice, because a placement fee on capital that never funds is a pure wound. And the sum of all this is the point managers feel in their bones: on a $400 million fund at two percent, the fee is $8 million – roughly one year of management fees, walking out the door of the management company, in installments that arrive exactly when the young firm needs the fee stream for payroll. That is why the threshold question is not what the fee is. In venture it is whether you should be paying it at all; in institutional private equity it is what, exactly, it is buying – and from whom.
Who should hire one – and who should not
In venture, and for emerging managers generally, the legitimate use cases come down to three, and they share a structure: a specific, nameable gap that the manager’s own network demonstrably cannot close.
The launch that will not happen otherwise. A first-time or early fund with a genuinely strong story – attributable track record, coherent strategy, credible team – that simply lacks the institutional relationships to get the meetings. This is the classic case and also the rarest one in practice, because the economics cut against it from both sides: the premier agents mostly will not take small first funds (the fee arithmetic does not justify their effort, and many maintain minimum mandate sizes), and the fees the willing agents charge are at their maximum exactly when the manager can least afford them. The first-time manager considering an agent should first exhaust the alternatives the market has built for exactly this situation – anchors, seeders and the emerging-manager ecosystem – and should hold any agent’s pitch up against a hard question: if the fund is as good as we both say, why does your fee need to be three percent?
The hole. An established manager loses an anchor – a sovereign changes policy, a pension consolidates relationships, a fund-of-funds fails to raise its own next vehicle – and faces a gap measured in nine figures with a fundraising calendar that will not wait. Here the agent is a surgical instrument: the mandate can be scoped to the gap, the agent’s network can be matched to the specific type of capital lost, and the fee, however painful, is priced against a genuine counterfactual (a smaller fund, or a longer raise, each with its own cost). Even here, the honest analysis sometimes lands elsewhere – a somewhat smaller fund returns to market sooner and may earn more carry per dollar – and a manager should run that analysis before the engagement letter, not after.
The roster rebuild. The most interesting case, and in our practice the most underused: the manager whose problem is not the amount of capital but its composition. Perhaps the roster is dangerously concentrated and a single re-up decision away from crisis. Perhaps it is full of difficult money – investors whose negotiation costs, operational demands or governance behavior consume more than their capital contributes. Perhaps the investor type is wrong for what the firm has become: a roster built on public pensions and sovereigns when the firm’s strategy, pace and disclosure posture now fit private capital better – or precisely the reverse, a private-capital roster that cannot scale with the franchise. The track record supports the roster the manager wants; the relationships do not exist to reach it. This is the placement agent as roster architect rather than gap-filler: a deliberate, one-or-two-vintage program to migrate the LP base, using an agent whose book is concentrated in exactly the capital the manager is moving toward. It is the use case that best survives the fee arithmetic, because the value purchased is not this fund’s marginal dollar but the durability of every fund after it.
In institutional private equity, the calculus inverts. The three cases above still describe when the fee earns itself hardest, but the baseline expectation is different: on a competitive institutional raise, professional distribution is assumed. The megafirms answer the need with in-house investor relations teams the size of small agencies; nearly everyone else answers it in the market – with the result that the question facing most private equity sponsors is not whether to engage placement help but which firm, at what scope, on what terms. Nobody reads an agent on a buyout raise as a confession; if anything, a large institutional raise attempted with no professional distribution at all invites its own quiet question. The venture reader should therefore hear the framework above at full volume, and the private equity reader should hear it as the exception-check it is – and both should hear what follows identically, because it is industry-agnostic.
And the illegitimate case, which explains more engagements than anyone admits: raising capital for the sake of raising capital. The opportunity set maps to the fund size, and the mapping is not negotiable by wanting it to be otherwise – a seed-stage venture fund should not be a billion dollars, and a lower-mid-market buyout strategy does not become a mid-market strategy because the roster grew. A manager who is right-sized and hires an agent to get bigger has made two mistakes at once: paying the market’s most expensive fee to acquire a problem, and signaling – to investors who read these things fluently – that the firm’s ambition has decoupled from its opportunity. The agent, it must be said gently, is the wrong person to ask. The best houses do decline mandates they do not believe in – an agent’s reputation is its underwriting, and the strong ones guard it – but once engaged, no fee schedule in our review ever paid an agent more for recommending a smaller fund, and the escalating tiers we found are that arithmetic written down. The size decision must be made before the agent enters the room, by people whose economics do not depend on the answer.
The signaling question
Does hiring an agent tell the market your network is weak? The honest answer is forked by industry. In institutional private equity, the question barely exists: agents are standard equipment, investors see them on a large share of the raises that cross their desks, and no inference attaches – if anything, on a billion-dollar raise, the absence of any professional distribution invites its own quiet question. In venture, the question is live, and the answer is yes and no, with the difference entirely within the manager’s control. Hired for one of the legitimate reasons and messaged accordingly – we are entering the Gulf for the first time and engaged coverage there; we are deliberately rebuilding toward private capital; we lost a cornerstone to a policy change and retained help to replace it – the engagement reads as professionalism, and investors, who see agent-assisted raises constantly, take no negative inference. Hired to paper over weak demand, no message survives contact with the market’s diligence. And in both markets there is a second-order signal managers underweight: which agent. The agent’s own standing becomes part of the fund’s presentation – a mandate with a firm the market regards as a last resort tells investors what the first resorts said, while a mandate below the manager’s perceived station raises its own questions. The prominence of the agent should match the position the manager claims; a mismatch in either direction is legible, and the market’s read of it can outlast the fundraise and touch the brand itself.
What you are buying, and the scope of the mandate
What agents actually do is broader than the introduction service of popular imagination, and the engagement letters describe it in nearly identical lists: positioning and materials (the deck, the data room, the diligence package built to institutional expectations), the target map and the calendar, meeting logistics and the discipline of the follow-up funnel, market intelligence on terms and investor appetites, negotiation support through closing, and – the underrated item – the feedback loop, since prospects tell agents truths they soften for principals. On a market backdrop where institutional raises now average a year and a half from first meeting to final close, with a third running past two years, the process management is not decoration. It is a large part of the product.
The scope architecture then follows the problem. The dominant form in our review, as in the market, is the global exclusive: one agent, all geographies, all investors except the carve-outs, and the top-tier houses generally insist on it – they will not share a mandate they are staking their name to. The exceptions are purposeful. Regional mandates – we reviewed one scoped solely to six Gulf jurisdictions, sole agent for the Middle East and nothing else, with a separate carve-out even there for retail-channel intermediaries – suit the roster-rebuild and new-geography cases precisely because they buy exactly the missing relationships and nothing redundant. The mandate forms of the non-US houses arrive with sub-agent architecture built in: affiliated entities in London, Frankfurt, Hong Kong, approved local firms for Korea and Japan, each wired into the letter with the primary agent liable for their conduct and the fee shared invisibly to the manager. Multi-agent structures – different agents for different regions – exist and can work, but they import a coordination cost (two agents, one prospect, one embarrassing collision) that the documents manage with jurisdiction lists and consent requirements, and that the manager manages, in practice, by being the air-traffic controller. And beneath every scoping decision sits the strategy question that should have preceded it: if you are hiring Gulf coverage, why are you entering the Gulf, and what does that capital do to the roster you are trying to build? An agent mandate is a distribution decision, and distribution decisions are strategy.
The engagement letter, walked commercially
Now the document itself, in the order the money moves. Everything below reflects patterns across the agreements we reviewed; everything is negotiable, a claim we can make with unusual confidence because one document in our sample was an agent’s unexecuted form with the drafting notes still in the margins – a reminder that the letter on your desk is the ask, not the answer.
Who counts: the carve-out war. The single most negotiated commercial issue is which investors generate fees, and the documents have evolved elaborate machinery for it. The manager’s existing relationships go on excluded-investor schedules – we saw lists running to fifty names – or reduced-fee schedules at token rates; new prospects get sorted through an “included investor” or list-based mechanism, often amendable only by mutual consent. The definitional core is what “introduced” means, and the best documents answer it with process rather than adjectives: an investor counts if the agent arranged a substantive meeting within a defined window (one form: 180 days from listing, 90 for late additions); the agent maintains a written log of arranged meetings, delivers it on a schedule, and the manager has a fixed period – thirty days in one recent letter – to dispute names, after which the log binds. Managers should fight for exactly this mechanical clarity, because the alternative is the dispute the courts are now seeing: a fee fight turning on whether “introduced” was even the operative standard, litigated years later on an incomplete record. Watch, too, the quiet expansions: consultant- and gatekeeper-advised investors defaulting to full-fee status unless the consultant holds discretion; re-ups by agent-introduced investors generating fresh fees in the next vehicle (common market practice, and the beginning of the franchise reach discussed below); and the schedule-stuffing dynamic at signing, where the agent’s proposed included list arrives long and the manager’s job is to shorten it with evidence. One more wrinkle from the review, spicier than it looks: a recent form provides expressly that an investor’s side letter forbidding the manager to pay intermediaries on its commitment does not relieve the manager of the fee. The agent gets paid even on capital that stipulated against it – out of the manager’s pocket, where the fee always lived anyway.
Getting paid, and staying solvent while doing it. The installment structures, interest mechanics and default adjustments described above are where a smaller manager’s engagement gets survivable or does not. The negotiating agenda: map every payment date to a management fee date (the good forms already do); resist acceleration; insist on the defaulting-investor recalculation and its cousin, the regulatory-removal adjustment; cap expenses (the documents cap them at ten to fifty thousand dollars, with per-item consent thresholds as low as two thousand); and model the whole schedule against the management company budget before signing, because a fee that is affordable against the raise is not always affordable against the quarters in which it falls due. As for the exotic structures: carried interest in lieu of cash fees exists mostly down-market and is rare in institutional practice – in our experience almost never, and the agents one would most want do not ask for it – while the opposite gesture, the agent investing its own capital in the fund, appears repeatedly in the documents (rights to invest a stated amount, sometimes on friends-and-family terms) and is worth granting: an agent with money in the fund is making the only representation about the product that cannot be drafted.
The people terms. Placement is a personal-services business wearing an institutional letterhead, and the sharpest managers now draft accordingly. The known failure mode – the senior partner who wins the mandate and the junior team that works it – is real enough that the market literature warns of it in exactly those words. The response we use, and saw reflected in the documents: name the individuals. The engagement designates the one or two senior people who sold you the relationship, requires them to devote substantial time to the mandate, and makes their departure or reassignment a cause event – termination rights, fee consequences – precisely the way a fund’s own key person clause treats the manager’s principals. It is the same logic pointed in the other direction, and agents who resist it are telling you something about their staffing plans. The agents’ own people terms run the other way: non-solicitation covenants barring the manager from hiring the agent’s staff, in one document backed by liquidated damages of five times the individual’s annual compensation. Both sides, it turns out, think the people are the product.
The tail – and then the franchise reach. Every letter has a tail: commitments closing within a window after termination still pay, on investors the engagement touched. Twelve months is the modal answer in our review, with eighteen appearing, and the real negotiation is the trigger – the spectrum runs from tight (investors with whom a substantive meeting occurred and as to whom the agent was the effective cause of the investment) to loose (anyone the agent “contacted” or, in one form, merely discussed), and every step along it is money. Tails are old technology and fair in principle; an agent should not be terminable into a free close of the pipeline it built. What is new is what comes after the tail, and here the review’s clearest finding emerges: the most recent documents reach for the next fund, and the reach is intensifying. The mechanisms escalate. A 2025 letter carries an express successor-fund fee – fifty basis points on any introduced investor who re-ups into the next blind pool. A 2026 letter builds a trailer fee into Fund IV at full rates for investors the agent merely met or discussed during this engagement, whether or not they invested in Fund III. And the most aggressive recent form grants the agent a right of first offer to serve as exclusive placement agent for the successor fund outright – with a fallback, if the ROFO negotiation fails, of fees on a named list of introductions who skip this fund but appear in the next one. The older agreements in the sample have none of this beyond ordinary sunsets. The direction of travel is unmistakable, and so is its commercial logic – which is worth stating without indignation, because none is warranted: agents are building franchise positions for the same reason managers build them, and an option on the next fund is worth far more than a fee on this one. The manager’s discipline is not to resent the ask but to price it – narrow the successor definitions, cap the trailer classes, convert rights of first offer into rights of first conversation, and remember that the incumbency you are granting is exactly the asset you may want to auction next time.
The continuation-vehicle frontier. The same review caught the newest reach in the act, from both directions at once. On one side, the most recent mandate forms now expressly exclude continuation vehicles, restructurings and secondary transactions from the fund definition, the successor-fund definition and the tail – exclusion language that precise gets drafted only after someone reached for the thing, which is to say the managers’ lawyers have started fencing. On the other side, an agent’s recent form grants it a right to bid on any manager-initiated secondary sale or fund restructuring, and another engagement staples an exclusive LP-led secondary mandate onto the primary raise – the agent authorized to broker existing investors’ interests in prior funds, earning a one percent seller-paid fee on those trades plus placement fees on any stapled new commitments. None of this is mysterious once you know that a few of the same houses now run substantial secondary and GP-led advisory businesses at fees of two to four percent of transaction value: the primary mandate has become the distribution channel for the higher-margin product. A manager signing a placement engagement in this market should read the definitions of “Fund,” “Successor Fund” and “Securities” with continuation vehicles specifically in mind – and should decide, deliberately and in advance, whether the primary agent is being granted, denied, or merely given a courtesy call on the transactions our continuation funds primer describes.
Termination and its aftermath. Convenience termination on thirty days’ notice is standard; we saw ten days in the newest letters – after an initial twelve-month lock – and ninety-day locks following the launch of marketing in others. The mechanics that matter are the survival ones: which fees accrue through termination, which pipeline converts under the tail, what the agent must hand over (the contact log, the status report – the documents increasingly require a full written accounting of every prospect touched), and the asymmetries by termination type (a for-cause termination generally cuts the fee tail; a convenience termination generally does not). One automatic trigger appears across the forms and deserves its own sentence: expulsion from FINRA terminates the engagement instantly, no notice required – the whole edifice rests on the agent’s registration, and the documents know it.
The rescue engagement
A special word on the mid-raise hire, because it is where the most money meets the least leverage. A fundraise stalls – the first close came in light, the pipeline aged, the market turned – and the manager reaches for professional help a year late. The honest facts: rescue mandates carry the worst economics in the market (the agent is underwriting a demonstrated demand problem and prices accordingly), the strongest agents frequently decline them (a stalled raise is reputational risk on someone else’s fund), attribution disputes concentrate in them (an agent arriving mid-stream inherits a pipeline full of half-touched prospects, which is precisely the fact pattern now producing fee litigation), and the signaling double-bind is real – the market eventually learns the cavalry was called, and reads it. Sometimes the rescue is still right: a completion mandate tightly scoped to a nameable gap, with fee credit only for genuinely new work, can convert an eighteen-month grind into a respectable final close. But the first professional question in every stalled raise is the one from our fundraising discussion above, and it is usually the answer: is the problem the distribution, or the size? A rescue engagement that throws fees at a sizing problem buys a bigger fund and a worse outcome. The cheapest agent in a stalled raise is frequently a smaller hard cap.
Choosing: the Rolodex discipline
Which brings us to selection, and to the largest single mistake we see – larger than overpaying, larger than the tail, large enough that we will state it as a rule: managers do not figure out whose Rolodex they are getting. The failure has a psychology. An agent of standing agrees to take your mandate; gratitude arrives before diligence; the brand on the letterhead stands in for the question that actually matters, which is: what are the actual relationships – institution by institution, type by type – of the actual individuals who will work this engagement, and do they match the register this fund needs?
A composite from practice, because the pattern teaches better than the rule. A manager comes to market with real holes – anchors lost, a gap in the hundreds of millions – atop a register that was, by design, entirely private capital: family offices, funds-of-funds, private institutions; not one difficult name; no public money and no apparatus for it. The manager hires a prominent agent, reputation impeccable, and does not ask the Rolodex question. The answer, it emerges, is that the firm’s book – and specifically the books of the two senior people on the mandate – is public pension plans, nearly to a name. The agent performs: the meetings happen, the checks come. And with the checks comes everything the roster was built to avoid: heavier negotiation, tougher terms, side letters with sunshine-law mechanics, public-records exposure, the full operating apparatus of public money, permanently, for capital the firm’s model never needed in that form. The raise “succeeded.” Years later, the people who lived it mostly agree the fund should have been smaller – or, more precisely, that it needed a different agent, one whose relationships matched the register the firm actually wanted. The diligence that would have revealed the mismatch was a week of phone calls. Nobody made them.
The discipline, then. Reference the agent the way an investor references you: call fund managers – comparable ones, recent ones – who used this firm and, if possible, these individuals; ask what was promised and what arrived, whose relationships produced the commitments, and whether the seniors who pitched stayed on the field. Demand the prospect map before signing – which institutions, which types, matched against the register you are trying to build, not merely the dollars you are trying to raise – and treat a mismatch as disqualifying no matter what the letterhead says. Name the people in the document, key-person style, as above. And run the composition test one more time at the end: every check an agent produces arrives with the negotiating posture, governance demands and disclosure consequences of its type attached, and the register you build this fund is the firm you will be operating for the next decade. (Those consequences compound through the side letter machinery in ways our side letters primer describes; difficult money is expensive twice.)
The regulatory map, in plain English
The regulatory story is short to tell and expensive to ignore, and it explains half the paper in the engagement letter. Start with the entry ticket: transaction-based compensation for selling fund interests requires broker-dealer registration, full stop, and the “finder” who takes a percentage without it is a securities-law violation with the manager’s name attached – the one corner of this subject where the answer is never commercial. Then the architecture built by scandal: after pay-to-play schemes nearly destroyed the industry’s legitimacy fifteen years ago, the SEC’s rule made it unlawful for an adviser to pay any third party to solicit government investors unless that party is a “regulated person” – a registered broker-dealer or adviser itself subject to pay-to-play discipline – and the states and plans layered on lobbyist-registration regimes, placement-agent disclosure forms, and in some cases outright bans. The engagement letters wear all of it: regulated-person representations, two-year contribution lookbacks running in both directions (the documents now make the manager represent its own political contributions to the agent), lobbyist-registration cooperation covenants, and – a mechanic worth admiring – the compensation-prohibition spring-back, under which a fee barred by an investor’s pay-to-play rules revives automatically if the prohibition lifts within a year. The 2021 marketing rule added the newest stratum, visible in every recent document like a tree ring: a paid placement agent is a compensated endorser, so the letters now choreograph the delivery of conflict-and-compensation disclosures to every prospect, down to prescribed disclaimer language in the agent’s emails. Two-way bad-actor representations, automatic termination on FINRA expulsion, sanctions and AML machinery, and – in the non-US mandate forms – GDPR processing terms and local-regulator classifications round out the stack. None of this is the manager’s compliance program by itself, and the allocation of these burdens in the letter is negotiated like everything else; but a manager should read the representations it is giving as carefully as the ones it is getting, because several of them – the contribution lookback above all – are representations about the manager’s own house.
Practical market observations
Pulling the threads together, a few observations from the field:
- Size first, agent second – always – and know which market’s question you are answering. In venture the threshold question is whether; in institutional private equity it is which firm and how scoped. In both, the fund’s right size is a function of the opportunity set, decided by people whose economics do not improve when the answer is bigger, and an agent hired to grow a right-sized fund is the market’s most expensive way to acquire a problem.
- Buy the person, not the letterhead. The mandate’s value lives in the specific relationships of the specific individuals assigned. Demand the prospect map, reference like an investor, match the book to the register you want – and then name those individuals in the document with key-person consequences, because the senior-pitch, junior-execution switch is common enough to have entered the folklore.
- The register you build is the firm you become. The most sophisticated use of an agent in the current market is not gap-filling but roster architecture – deliberately migrating the LP base toward the capital that fits the franchise. Run every engagement, even the defensive ones, through that lens: each check arrives with its type’s negotiating posture and governance apparatus permanently attached.
- Fight for mechanics, not adjectives. The fee disputes now reaching courtrooms turn on ambiguous attribution. The cure is in the drafting the best documents already use: meeting-based triggers with defined windows, written logs, fixed dispute periods, effective-cause standards on the tail. Insist on the machinery.
- Map the payments to the fee stream and model the squeeze. Installments timed to management fee dates, interest understood, defaulting-investor recalculations included, expenses capped – and the whole schedule tested against the management company budget for the quarters in which it actually falls due.
- Price the future or refuse to pledge it. Successor-fund fees, trailer classes, rights of first offer, continuation-vehicle reach – the newest letters option the franchise at a price of zero. Read the definitions of Fund, Successor Fund and Securities with the next decade in mind, fence the continuation vehicles deliberately, and remember that incumbency on your next raise is an asset you may want to sell in an auction, not give away in a boilerplate.
- Treat incumbency as an asset with a price. The agent that raised this fund starts the next one owning the relationships you paid it to build. Rolling the mandate forward is often exactly right – but do it as a decision, priced against an alternative, not as a default inherited from a boilerplate right.
- Message the hire like the strategic act it is. The right reason, said out loud, converts the signaling question from liability to credential – and the caliber of the agent is part of the message, in both directions.
- And if the raise has stalled, ask the sizing question before the rescue question. The completion mandate has its place, tightly scoped and honestly priced; but the cheapest agent in most stalled raises is a smaller hard cap, and the courage to take it.
Conclusion
A placement agent engagement is a large, personal check written for someone else’s relationships, and everything in this primer reduces to making sure the relationships are the right ones and the check buys only what you mean to sell. The market’s terms are knowable: fees with a center of gravity and a wide, negotiable edge; carve-outs and attribution machinery that reward precision; payment mechanics that can be shaped to the fee stream that funds them; people terms that can hold the seniors who sold you the mandate; and a quietly expanding frontier – successor funds, trailers, continuation vehicles – where the agents are converting fundraising mandates into franchise positions one boilerplate definition at a time. The manager’s side of the bargain is discipline: about size before distribution, about whose Rolodex is actually on offer, about the register the firm is building and not merely the total it is raising – disciplines that hold whether the agent is your market’s exception or its standard equipment.
The questions, in the end, are the ones we opened with. Do you need one – for which nameable gap, or, in the market that presumes the answer, which firm and at what scope? Whose relationships are you buying – and do they match the investor base you want to live with? And what does the letter reach beyond this fund – at what price, pledged how knowingly? These questions are related, but they are not the same – and the managers who answer all three before signing are the ones for whom the most expensive hire in fund management turns out, occasionally and gloriously, to be worth every basis point.
The authors
